Source - Alliance News
AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Prices two tranches of eurobonds, raising a total of €1.40 billion for ‘general corporate purposes’. Issues €650 million in fixed-rate notes with a coupon of 3.121% maturing in August 2030, and €750 million in fixed-rate notes with a coupon of 3.278% maturing in August 2033. The offering, by subsidiary AstraZeneca Finance LLC, is run by BNP Paribas, Goldman Sachs International, Morgan Stanley and Societe Genarale as joint book-running managers.
Current stock price: 12,259.34 pence, down 0.9% in London on Tuesday
12-month change: up 9.6%
Copyright 2024 Alliance News Ltd. All Rights Reserved.
